Cross-border M&A, deal structuring, due diligence, and corporate finance strategies for mid-market and enterprise transactions.
The KKR-led bid for Tatts Group, Ant Financial’s helloPay acquisition, and the government-backed race for Toshiba’s semiconductor division signal a new phase in cross-border M&A driven by private equity and state capital. Senior executives must recalibrate due diligence, regulatory strategy, and post-merger integration frameworks to compete effectively.
Sun Pharmaceutical Industries’ $11.75 billion acquisition of a U.S. drug manufacturer marks the largest cross-border deal by an Indian pharma firm, signalling a structural shift in global M&A dynamics. CFOs and General Counsel must now reassess due diligence frameworks, regulatory exposure, and post-merger integration strategies in response.
Sun Pharma’s record $11.75 billion all-cash acquisition of a U.S. drug manufacturer marks a structural shift in cross-border M&A, as Asian capital moves decisively into Western pharmaceutical markets. Alongside Eli Lilly’s $2.3 billion oncology bolt-on and Shell’s $16.4 billion energy consolidation, these deals define the strategic and regulatory imperatives facing M&A decision-makers in 2025.
KKR’s revised $615 billion bid for Tatts Group and Chevron’s $109 billion Canadian divestiture headline a new wave of cross-border M&A reshaping Asia-Pacific deal strategy. European decision-makers face mounting pressure to front-load regulatory due diligence and build robust post-merger integration frameworks across multiple jurisdictions.
The $130 billion DuPont–Dow merger and a surge of cross-border acquisitions in biotech, private equity, and digital are redefining how M&A is structured and executed globally. Decision-makers must align due diligence, post-merger integration, and regulatory strategy from day one to capture deal value.
The EU’s formal investigation into JD.com’s €2.2 billion bid for Ceconomy under the Foreign Subsidies Regulation marks a structural shift in how cross-border M&A involving non-EU capital will be scrutinised in Europe. CFOs and M&A Directors must now embed FSR compliance and extended regulatory timelines into deal planning from the outset.
The EU’s FSR investigation into JD.com’s €2.2B bid for Ceconomy signals a structural shift in cross-border M&A risk for European targets. Deal teams must now integrate foreign subsidy screening, extended regulatory timelines, and remedies risk into core transaction planning from the outset.
The European Commission’s FSR probe into JD.com’s €2.2 billion bid for Ceconomy signals a structural tightening of regulatory scrutiny for Asian acquirers in Europe. M&A teams must now integrate foreign subsidy risk assessment into deal origination, financing structures, and due diligence protocols from day one.
The EU’s formal FSR investigation into JD.com’s €2.2 billion Ceconomy bid signals a new compliance frontier for cross-border M&A in Europe. M&A directors, CFOs, and General Counsel must integrate foreign subsidy analysis into deal structuring from the earliest stages of origination.
Over $96 billion in M&A deals were announced in a single 24-hour period, driven by cheaper financing, easing geopolitical tensions, and structural consolidation logic across sectors. For CFOs and M&A Directors, the strategic window is open — but regulatory complexity, particularly under the EU Foreign Subsidies Regulation, demands immediate attention.